Samnidhy | Company Analysis

Company Analysis of Sun Pharma

Company Analysis Tega

Sun Pharmaceutical Industries Ltd, the fourth largest specialty generic pharmaceutical company globally with revenues exceeding US$ 5.1 billion, operates a network of over 40 manufacturing facilities. This infrastructure enables them to provide high-quality, cost-effective medicines, positioning them as a trusted choice for healthcare professionals and patients in more than 100 countries. Founded in 1983 by Mr. Dilip Shanghvi with an initial investment of INR 10,000 (US$150), Sun Pharma initially served as a pharmaceutical wholesaler.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Company Analysis of Interglobe Aviation

Interglobe Aviation Ltd, operating under the brand name IndiGo, stands as India’s...

Company Analysis of Aditya Birla Capital

Aditya Birla Capital Ltd. (ABCAPITAL) is the Aditya Birla Group’s financial services...

Company Analysis of Kotak Mahindra Bank

In February 2003, Kotak Mahindra Finance Ltd. (KMFL), the Group’s flagship company,...

Company Analysis of Dixon Technologies

About the company: Dixon Technologies offers services for the manufacturing and design...